Piper Sandler's Rating of AbbVie on 11/18/2026

On November 18, 2026, Piper Sandler updated its outlook on AbbVie (NYSE:ABBV) with the action "Set Price Target", setting a price target of $349.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Piper Sandler

DateCompanyAction
11/18/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Initiated Coverage
11/18/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Reiterated Rating
11/18/2026
ServiceTitan Inc. stock logo
TTAN
ServiceTitan
Set Price Target
11/18/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Set Price Target
11/18/2026
Innoviva, Inc. stock logo
INVA
Innoviva
Initiated Coverage
11/17/2026
Workday, Inc. stock logo
WDAY
Workday
Set Price Target
More Ratings From Piper Sandler